These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36575866)

  • 1. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
    Mahjoub TT; Milibary HH
    J Cosmet Dermatol; 2023 Apr; 22(4):1157-1162. PubMed ID: 36575866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE USE OF TRANEXAMIC ACID IN DERMATOLOGY.
    Gaćina K; Krstanović Ćosić A
    Acta Clin Croat; 2023 Aug; 62(2):368-372. PubMed ID: 38549597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update.
    Chen T; Xue J; Wang Q
    Clin Cosmet Investig Dermatol; 2024; 17():2151-2163. PubMed ID: 39350932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral tranexamic acid in the treatment of lichen planus pigmentosus: A prospective study of 20 cases].
    Zenjari L; Elfetoiki FZ; Hali F; Skalli H; Chiheb S
    Ann Dermatol Venereol; 2020 Dec; 147(12):818-822. PubMed ID: 32747031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging importance of tranexamic acid in dermatology.
    Forbat E; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2020 Jun; 45(4):445-449. PubMed ID: 31663643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid in melasma: A focused review on drug administration routes.
    Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Tranexamic Acid for Prevention and Treatment of Postinflammatory Hyperpigmentation.
    Minasyan M; Hogan S; Lal K
    Dermatol Surg; 2024 Dec; 50(12S):S219-S224. PubMed ID: 39347626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uses of tranexamic acid in dermatology: a review.
    Kim KM; Lim HW
    Int J Dermatol; 2023 May; 62(5):589-598. PubMed ID: 35323992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective clinico-pathological study comparing lichen planus pigmentosus with ashy dermatosis.
    Cheng HM; Chuah SY; Gan EY; Jhingan A; Thng STG
    Australas J Dermatol; 2018 Nov; 59(4):322-327. PubMed ID: 29635779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
    Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
    Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.
    Wang WJ; Wu TY; Tu YK; Kuo KL; Tsai CY; Chie WC
    Indian J Dermatol Venereol Leprol; 2023; 89(2):189-194. PubMed ID: 36332095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.